Seattle Genetics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (37)

Latest Posts

About This Stock More About This Stock
3 Stocks To Buy And Hold For The Next Decade: Eli Lilly, HCA Healthcare, And Seagen
Article By: StockNews
Saturday, February 13, 2021 11:00 AM EDT
If there is one lesson the COVID-19 pandemic has taught humanity, it is to value our health over all else.
In this article: HCA, LLY, SGEN
Read
4 Cutting-Edge Healthcare Stocks To Buy For 2021
Article By: StockNews
Wednesday, November 4, 2020 6:46 AM EDT
Healthcare has previously been considered a defensive sector, but with the growth in biotech and medical services companies to meet the demands of the coronavirus pandemic, the future of these industries, and the sector overall, look quite promising.
In this article: LHCG, MASI, SGEN, AMED Also: MRK
Read
5 Big Pharma/Biotech Stocks Set To Trump Q3 Earnings Estimates
Article By: Zacks Investment Research
Tuesday, October 20, 2020 4:42 AM EDT
Pharma stocks include large and small drug makers as well as biotechs focused on developing novel therapies.
In this article: BMY, GSK, MRK, SGEN, VRTX
Read
Seattle Genetics Downgraded To Neutral From Overweight At Piper Sandler
Article By: The Fly
Friday, July 24, 2020 8:10 AM EDT
Piper Sandler analyst Joseph Catanzaro downgraded Seattle Genetics to Neutral from Overweight with a price target of $165, up from $155.
In this article: SGEN
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes
Monday, September 9, 2019 7:36 PM EDT
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read

Latest Tweets for $SGEN

No tweets yet!

$SGEN

Large Cap Biopharmaceuticals Performance Update 2018: Part 2
Harry Goldstein 2/20/2018 9:31:10 PM

Why did you decide to purchase $SGEN?

Seattle Genetics Receives FDA Halt On Several Phase 1 Studies
Caitlin Snow 1/3/2017 7:11:44 PM

A real tragedy, not just for $SGEN investors, but for the families of those who died as a result of the trials. How likely is it that the company can bounce back from something like this?

1 to 2 of 2 comments